Will US-Japan trade deal weigh in on Sensex, Nifty today?
advertisement
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
7 minutes ago
- Time of India
Mid-sized GCCs out-hire larger peers with double-digit growth in first half
Academy Empower your mind, elevate your skills ETtech Mid-size global capability centres (GCCs) in India are outpacing the large ones in hiring, according to data sourced by by mid-size GCCs , or those with 500–2,000 employees, increased 10–12% in the six months through June, compared with 4–6% by large GCCs , showed data from staffing services provider Quess Corp Most of the hiring by mid-size GCCs is aimed at replacing outgoing employees or expanding existing teams, said Quess Corp IT Staffing CEO Kapil Joshi. 'These centres are focused on long-term stability, process maturity, and cost efficiency.'To be sure, large GCCs, with more than 2,000 employees, still make up the majority of the workforce and continue to grow, albeit at a slower pace than in the the GCC wave is growing in India, large multinationals that already employ thousands in Indian GCCs are opting for leaner teams and sharper focus to make the workforce more agile and adapt quickly to business needs in the wake of the disruption from artificial large GCCs bring scale and reliability, the mid-size ones are leading the way in capability-led hiring, said relatively smaller firms are entering India for the first time or expanding operations quickly, building entire capabilities from the ground up, said Joshi. 'To attract the right talent, they are offering competitive salaries, signing bonuses and quicker career growth, especially for skilled professionals in AI and data roles…They're not just hiring more people, they're hiring differently, with a clear goal to build new capabilities and gain a competitive edge in the talent market.'Over the last five years, the headcount at mid-size GCCs grew 46%—to more than 220,000 in 2024 from 150,000 in 2019—compared with a 34% expansion in the workforce at other GCCs, showed data from ANSR that helps MNCs set up non-mid-market GCCs, largely comprising big GCCs, employed 1.68 million people in 2024, up from 1.25 million in GCCs are aggressively expanding in India. More than 45 new centres set up operations in the past two years alone, as per an April report by industry body Nasscom and consulting firm Zinnov. They account for nearly 35% of India's total GCCs, and 30% of the GCC additions during the past two operate under greater cost constraints than their larger peers, are rapidly evolving into significant contributors to their parent organisations' market strategies and are becoming influential players in their respective industries, according to sector centres are characterised by high maturity as transformation hubs, and deep product capabilities with a significant share of global product management talent. They have a high concentration of niche deeptech skills, a central role in global engineering, research & development (ER&D), an agile operating model enabling faster leadership elevation, and function as process transformation engines for their parents, say than 120 new mid-market GCCs are expected to be established in India by the end of 2026, adding about 40,000 jobs, ET had recently to the Nasscom-Zinnov report, the mid-market segment has the potential to attract at least 23–27% of the 130,000–150,000 global mid-market companies leading to AI-led transformation.
Mint
7 minutes ago
- Mint
Best stocks to buy today, as recommended by Raja Venkatraman for 28 July
A constant turbulence held its grip on the markets as there was no clarity on the indices. The stock-specific action that we were noticing has now stepped up, leading to the trading-oriented behaviour. The market scenario clearly indicates that investors are still waiting by the sidelines. Here are three stocks to buy or sell, as recommended by Raja Venkatraman of NeoTrader for Monday, 28 July. Best stocks to buy today—28 July PUNJABCHEM: Buy CMP and dips to ₹1,260 | Stop: ₹1,250 | Target: ₹1,460-1,520 AUTOAXLES: Buy CMP and dips to ₹1,860 |Stop: ₹1,845 | Target: ₹2,075-2,130 GREENPANEL: Buy CMP and dips to ₹302 | Stop: ₹298 | Target: ₹355-370 The stock market on Friday, 25 July Benchmark equity indices tumbled on Friday as growing uncertainty over the prospective India-US trade deal, with an 1 August deadline looming, dented market sentiment. By 11:30 am, the BSE Sensex was trading at 81,692.58, down 491 points, or 0.60%, having earlier slumped to an intraday low of 81,405.83—a drop of 778 points. The NSE Nifty followed suit, slipping below the 24,900 level to trade at around 24,930, off 169 points, or 0.68%, and hitting an early low of 24,806.35. Within the Sensex pack, only Bharti Airtel, Sun Pharma, and Tata Consultancy Services managed modest gains, while Bajaj Finance, Bajaj Finserv, Zomato, PowerGrid, and Infosys featured among the day's worst performers. Broader markets witnessed a steeper decline: the Nifty Midcap 100 fell 1.12% to 58,303.25, and the Nifty Smallcap index slid 1.53% to 18,400.60. With the trade-deal deadline drawing near, investors are adopting a cautious stance, awaiting clarity on tariff negotiations. Outlook for trading Despite the best intention to revive from lower levels the trends have been very fragile. Repeated attempts to head higher have been met with supplies, which is preventing a possible revival. The inability of the market trends to clearly hold on to indicate any direction has forced us to take a retreat as far as the bullish trends are concerned. The intermittent stock-specific action is not able to drive up sufficient momentum. We are noting that the trends are extremely pressured and this could lead to some sustained selling pressure in the coming week. As we now enter the expiry week the focus is shifting to the rollover activity that shall attract some buildup as anticipation for a recovery steps up. Now, we could shift our attention to upcoming corporate earnings in the coming month to help the prices rebound. Until then, there is no specific trigger. Higher timeframe charts are clearly indicating that the trends are now caught in a bearish overhang, especially the Nifty, which could push the market to close the current series below 25,000. The sharp rise seen in June came to an abrupt end since the start of the July series. Since then, the broader indices are making heavy weather about the recovery. As we wrap up this series, trends are not consistent and we are now moving in a neutral-to-negative setup. The bias, though muted, is still trying to salvage the bullish bias. The Open Interest is signalling that the PCR continues to be above 1 for Nifty, indicating that there is a strong defence of lower levels, and 25,000, which is the maximum pain point, will definitely be under contention. We have a huge short build-up of Puts at 25,000, which continues to highlight the defence against the selling pressure that persists at the moment. Some encouraging signs of global cues not giving up could help stem the pressure to go past 25,000, which has now turned into a resistance zone as we head into the current week. As no clarity exists even at this juncture, one should refrain from limiting short position at current levels or on rally towards 25,200 as the momentum is clearly divided. Three stocks to trade, recommended by NeoTrader's Raja Venkatraman PUNJABCHEM: Buy CMP and dips to ₹1,260 | Stop: ₹1,250 | Target: ₹1,460-1,520 AUTOAXLES: Buy CMP and dips to ₹1,860 |Stop: ₹1,845 | Target: ₹2,075-2,130 GREENPANEL: Buy CMP and dips to ₹302 | Stop: ₹298 | Target: ₹355-370 Raja Venkatraman is co-founder, NeoTrader. His Sebi-registered research analyst registration no. is INH000016223. Investments in securities are subject to market risks. Read all the related documents carefully before investing. Registration granted by Sebi and certification from NISM in no way guarantees performance of the intermediary or provide any assurance of returns to investors. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.
Economic Times
7 minutes ago
- Economic Times
Nifty resistance seen at around 25,500 levels: Analysts
Live Events Agencies (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel The Nifty closed below the 25,000 level on Friday after declining almost 1%, and this weakness is likely to continue in the short term, said analysts. While levels around 24,500 are expected to act as key support for the benchmark, resistance is likely around the 25,200–25,500 zone. VIX levels could also see an uptick, especially closer to the monthly expiry. However, pharma stocks could continue their upward TECHNICAL RESEARCH, MONARCH NETWORTH CAPITALThe benchmark index traded with a negative bias and closed below the psychological 25,000 level with a bearish formation. Bank Nifty outperformed the benchmark index and closed with an indecisive candlestick formation on the weekly chart. FIIs have continued to add shorts on index futures, and their net short positions have reached 86%. Historically, the market has witnessed a short-covering rally once shorts reach the 86-89% zone. Traders can expect volatile momentum in all indices during the monthly expiry week. Nifty has support at 24,500 and resistance at 25,200–25,500 levels. Bank Nifty has support at 56,000 and resistance at 57,200–58,000 has seen outperformance in last two weeks and may continue its outperformance. Biocon is the top pick; Cipla and Syngene are in accumulation zone. RIL has reached near weekly support level; investors can accumulate at current levels. Jindal Steel and Power may continue upward momentum. Nifty Defence index has broken below a key support level; HAL and Mazagon Dock Shipbuilders have closed with bearish candlestick formation, and a rally is a short-selling opportunity. Investors can look to accumulate Capri Global Capital, Saksoft, RACL Geartech, and NLC India at current EQUITY TECHNICAL & DERIVATIVE RESEARCH, CENTRUM BROKINGThe Nifty extended its losing streak for the fourth consecutive week. It faced strong resistance near its 21-DMA, currently around 25,300, which remains a key hurdle. It breached the support level of 25,000, which aligns with its 50-DMA, and this zone is now expected to act as a resistance. A decisive move back above 25,000 could trigger short covering, pushing the index towards 25,200. For the week ahead, the Nifty is likely to trade within a range of 24,500–25,200. The VIX seems to have found support near its multi-month low around 10-mark and has started inching higher, suggesting potential rise in market the monthly expiry approaching, markets are expected to remain volatile in coming week. We recommend focusing on stock-specific and sectoral opportunities rather than broader index moves. We are seeing sectoral rotation, with market focus shifting back towards defensive segments. The Pharma Index is exhibiting strength by forming a higher top–higher bottom structure, indicating positive short-term trend. Stocks such as Lupin, Cipla, Torrent Pharma, and Apollo Hospitals look well-positioned and can be considered for accumulation. In the insurance space, SBI Life and HDFC Life appear better placed. The IT sector is weighing down indices. The overall structure remains weak. As such, it is advisable to stay away from the sector for now. Additionally, oil & gas and FMCG sectors are also showing signs of weakness and lack nearterm TECHNICAL RESEARCH, MOTILAL OSWAL FIN SERVICESAfter an 18% rally from the April lows, Nifty has entered a corrective phase this July. Index closed the week below its 50-DEMA, and the RSI on daily and weekly charts continues to show a negative crossover. The index is expected to trade within a range of 24,600–25,250, and a decisive breakout above will be needed for resumption of uptrend. In case of a breakdown below 24,600, next support lies in previous swing low zone of 24,500–24, and smallcap indices remain in a consolidation phase. Most sectoral indices are showing signs of a pause or pullback. We continue to advise short-term traders to stay cautious. Pharma and healthcare could outperform, and selective opportunities can be considered in Torrent Pharma, IPCA Labs, and Max Health
